Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo


Request an Appointment

Cancer Answer Line:

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

Cancer Clinical Trials Results

CASE 5214 15-166 A Phase II Study of Second-Line Therapy with Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer Fairview, Hillcrest, Independence, Main Campus Phase 2Pancreas
CASE 6Y14 15-465 Integrated 3D x-ray and ultrasound Guided Radiation Therapy of Soft Tissue Target Main Campus  Liver, Pancreas, Prostate
CASE 921212-1317 Outcomes Registry of Patients with Pancreatic Cancer Undergoing Definitive Treatment at Cleveland Clinic Main Campus  Pancreas
EA 2142 16-073 Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas Fairview, Hillcrest, Independence, Main Campus, Mansfield, North Coast Cancer, South Pointe, Strongsville, Wooster Phase 2Pancreas
NHLBI-MDS 16-817 Protocol for the collection of information and samples to be used in the study of MDS Main CampusAdvanced/MetastaticPhase 2GI (Gastrointestinal), Myelodysplastic Syndrome (MDS), Pancreas

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).


Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.